Amorepacific reinforced its science-led approach to K-beauty in the U.S. through engagements with the New York Society of Cosmetic Chemists. At the NYSCC Scientific Committee Event, Vice President Jinseob Shin presented a split-face micro needling study of a barrier-strengthening formula, sharing results from a multiethnic clinical study that evaluated AESTURA's technology in supporting skin recovery after micro-needling. At NYSCC Suppliers' Day, Derma Science Director Michelle Shieh presented on emerging ingredients including PDRN, spicules, and exosomes, highlighting a study finding that PDRN nano-liposomes achieved up to 7.8 times enhanced delivery versus conventional liposomes. The company's Americas business grew 20% year-over-year in 2025, alongside the recent expansion of derma brands AESTURA and IOPE.
Amorepacific Corp. (New)Amorepacific presented science-led innovation at NYSCC, highlighting clinical studies and advanced delivery technology for its derma brands.